1. Homepage
  2. Equities
  3. China
  4. Shenzhen Stock Exchange
  5. Porton Pharma Solutions Ltd.
  6. Company
    300363   CNE100001S57

PORTON PHARMA SOLUTIONS LTD.

(300363)
  Report
End-of-day quote Shenzhen Stock Exchange  -  2022-06-23
76.62 CNY   +10.80%
06/13PORTON PHARMA SOLUTIONS LTD.(SZSE : 300363) added to Shenzhen Stock Exchange Component A Share Index
CI
06/13PORTON PHARMA SOLUTIONS LTD.(SZSE : 300363) added to Shenzhen Stock Exchange Component Index
CI
04/28Porton Pharma Solutions Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Porton Pharma Solutions Ltd., formerly Porton Fine Chemicals Ltd., is a China-based company principally engaged in the provision of customized pharmaceutical research and production services. The Company is also engaged in the multi-client product manufacturing businesses and pharmaceutical and chemical commerce businesses. The products of the Company include anti-viral, anti-diabetic, hypolipidemic, anti-cancer, anesthesia analgesia and anti-bacterial pharmaceuticals, among others. The Company operates its businesses in Europe, North America, Asia and China, among others.

Number of employees : 3 782 people.
Sales per Business
20202021Delta
Late Clinical and Commercial1 448.9569.9%2 038.5765.7% +40.69%
Early Clinical564.4727.2%972.8831.3% +72.35%
Others58.462.8%93.703% +60.27%
CNY in Million
Sales per region
20202021Delta
Foreign1 748.4384.4%2 426.1278.1% +38.76%
China323.4515.6%679.0321.9% +109.94%
CNY in Million
Managers
Name Title Age Since
Nian Feng Ju Chairman & General Manager 49 -
Wei Pi Securities Representative - -
Rong Tao Vice Chairman, Secretary & Deputy General Manager 59 -
Members of the board
Name Title Age Since
Nian Feng Ju Chairman & General Manager 49 -
Yong Qing Guo, Dr. Independent Director 47 -
Pei Min Zheng Independent Director 49 -
Ji Hong Lai, Dr. Independent Director 52 -
Rong Tao Vice Chairman, Secretary & Deputy General Manager 59 -
Xing Ming Li Member-Supervisory Board 47 -
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 550,500,333 285,847,137 51.9% 6,335,013 1.2% 51.9%
Shareholders
NameEquities%
Chongqing Liangjiang New District Industrial Group Co., Ltd. 78,982,719 17.6%
He Bing Zhang 41,903,020 9.36%
Zhong Ou Asset Management Co., Ltd 40,096,061 8.95%
GF Fund Management Co., Ltd. 36,688,414 8.19%
ICBC Credit Suisse Asset Management Co., Ltd. 31,302,584 6.99%
Zhangjiagang Zhuoyuan Investment Ptp LP 27,200,000 6.07%
Jiangsu Ruilian Investment Fund Management Co., Ltd. 23,927,560 5.34%
China Universal Asset Management Co., Ltd. 16,112,225 3.60%
Nian Feng Ju 14,722,630 3.29%
Chongqing Huilin Equity Invt Fund LP 14,442,350 3.22%
Company contact information
Porton Pharma Solutions Ltd.
Fangzheng Avenue
Shuitu Park Zone
Beibei District
Chongqing 400714

Phone : +86.23.65936900
Fax : +86.23.65936901
Web : http://www.porton.cn
Brand Portfolio
In partnership withAllbrands.markets
More brands of Porton Pharma Solutions Ltd.
Sector Other Pharmaceuticals
1st jan.Capi. (M$)
PORTON PHARMA SOLUTIONS LTD.-14.34%6 233
JOHNSON & JOHNSON5.02%462 443
ELI LILLY AND COMPANY17.88%276 070
PFIZER, INC.-15.17%275 327
ABBVIE INC.12.51%260 755
ROCHE HOLDING AG-19.20%259 627
NOVO NORDISK A/S3.80%244 293
MERCK & CO., INC.20.04%225 468
ASTRAZENECA PLC24.31%195 747
NOVARTIS AG-2.55%177 847
BRISTOL-MYERS SQUIBB COMPANY26.64%162 980
AMGEN INC.9.07%128 283
SANOFI13.52%125 452
GSK PLC9.17%105 830
BAYER AG22.96%62 747
DAIICHI SANKYO CO., LTD.10.70%46 113
TAKEDA PHARMACEUTICAL COMPANY LIMITED18.11%42 489
CHUGAI PHARMACEUTICAL CO., LTD-7.01%42 433
JIANGSU HENGRUI MEDICINE CO., LTD.-33.90%31 363
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD-21.70%30 338
ASTELLAS PHARMA INC.14.94%28 769